Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 371

1.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome.

Ann Rheum Dis. 2002 Jun;61(6):554-8. Review.

2.

Bax gene expression alters Ca(2+) signal transduction without affecting apoptosis in an epithelial cell line.

Aiba-Masago S, Liu Xb XB, Masago R, Vela-Roch N, Jimenez F, Lau CM, Frohlich VC, Talal N, Dang H.

Oncogene. 2002 Apr 18;21(17):2762-7.

3.

Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndrome.

Jimenez F, Aiba-Masago S, Al Hashimi I, Vela-Roch N, Fernandes G, Yeh CK, Talal N, Dang H.

Rheumatology (Oxford). 2002 Mar;41(3):338-42.

PMID:
11934973
4.

Fas-mediated apoptosis in a rat acinar cell line is dependent on caspase-1 activity.

Aiba-Masago S, Masago R, Vela-Roch N, Talal N, Dang H.

Cell Signal. 2001 Sep;13(9):617-24.

PMID:
11495719
5.

Sjögren's syndrome: an historical perspective.

Talal N.

Ann Med Interne (Paris). 1998 Feb;149(1):4-6. No abstract available.

PMID:
11490516
6.

TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.

Nakabayashi T, Sakata KM, Sakata A, Kong L, Lau CA, Letterio JJ, Vela-Roch N, Talal N, Dang H.

Inflammation. 2001 Apr;25(2):69-73.

PMID:
11321361
7.

Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.

Masago R, Aiba-Masago S, Talal N, Zuluaga FJ, Al-Hashimi I, Moody M, Lau CA, Peck AB, Brayer J, Humphreys-Beher MG, Dang H.

Arthritis Rheum. 2001 Mar;44(3):693-702.

8.

G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells.

Liu XB, Masago R, Kong L, Zhang BX, Masago S, Vela-Roch N, Katz MS, Yeh CK, Zhang GH, Talal N, Dang H.

Cell Death Differ. 2000 Nov;7(11):1119-26.

9.

What is Sjögren's syndrome and why is it important?

Talal N.

J Rheumatol Suppl. 2000 Dec;61:1-3. Review. No abstract available.

PMID:
11128697
10.

Monocyte rescue of human T cells from apoptosis is CD40/CD154 dependent.

Sakata K, Sakata A, Kong L, Vela-Roch N, Talal N, Dang H.

Scand J Immunol. 1999 Nov;50(5):479-84.

11.

Sjögren's syndrome comes of age.

Anaya JM, Talal N.

Semin Arthritis Rheum. 1999 Jun;28(6):355-9. Review. No abstract available.

PMID:
10406403
12.

The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome.

Humphreys-Beher MG, Peck AB, Dang H, Talal N.

Clin Exp Immunol. 1999 Jun;116(3):383-7. Review. No abstract available.

13.
14.

Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.

Kong L, Robinson CP, Peck AB, Vela-Roch N, Sakata KM, Dang H, Talal N, Humphreys-Beher MG.

Clin Exp Rheumatol. 1998 Nov-Dec;16(6):675-81.

PMID:
9844759
15.

Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes.

Sakata K, Sakata A, Vela-Roch N, Espinosa R, Escalante A, Kong L, Nakabayashi T, Cheng J, Talal N, Dang H.

Eur J Immunol. 1998 Sep;28(9):2648-60.

16.

Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction.

Kong L, Ogawa N, McGuff HS, Nakabayashi T, Sakata KM, Masago R, Vela-Roch N, Talal N, Dang H.

Clin Immunol Immunopathol. 1998 Aug;88(2):133-41.

PMID:
9714690
17.

Cytokines may prove useful in the treatment of Sjögrens syndrome (SS) dry eye.

Talal N, Nakabayashi T, Letterio JJ, Kong L, Geiser AG, Dang H.

Adv Exp Med Biol. 1998;438:953-8. Review. No abstract available.

PMID:
9634993
18.

CD4 mononuclear cell infiltrates and Fas/Fas ligand positive mammary gland cells in breast tissue from a patient with Sjögren's syndrome.

Attias MR, Kong L, Tortolero M, Maccarone BG, Nakabayashi T, Talal N, Dang H.

J Rheumatol. 1998 Jun;25(6):1226-31.

PMID:
9632092
19.

Role of Fas/FasL interaction in physiology and pathology: the good and the bad.

Sakata K, Sakata A, Kong L, Dang H, Talal N.

Clin Immunol Immunopathol. 1998 Apr;87(1):1-7. Review. No abstract available.

PMID:
9576004
20.

Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice.

Nakabayashi T, Letterio JJ, Geiser AG, Kong L, Ogawa N, Zhao W, Koike T, Fernandes G, Dang H, Talal N.

J Immunol. 1997 Jun 1;158(11):5527-35.

PMID:
9164977
21.

Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome.

Kong L, Ogawa N, Nakabayashi T, Liu GT, D'Souza E, McGuff HS, Guerrero D, Talal N, Dang H.

Arthritis Rheum. 1997 Jan;40(1):87-97.

PMID:
9008604
22.

Pooled human immunoglobulins contain anti-idiotypes with reactivity against the SLE-associated 4B4 cross-reactive idiotype.

DeKeyser F, DeKeyser H, Kazatchkine MD, Rossi F, Dang H, Talal N.

Clin Exp Rheumatol. 1996 Nov-Dec;14(6):587-91.

PMID:
8978951
23.

Lymphocyte apoptosis and apoptosis-associated gene expression in Sjögren's syndrome.

Ogawa N, Dang H, Kong L, Anaya JM, Liu GT, Talal N.

Arthritis Rheum. 1996 Nov;39(11):1875-85.

PMID:
8912510
24.

Abnormality of Oct-1 DNA binding in T cells from Sjögren's syndrome patients.

Flescher E, Vela-Roch N, Ogawa N, Nakabayashi T, Escalante A, Anaya JM, Dang H, Talal N.

Eur J Immunol. 1996 Sep;26(9):2006-11.

PMID:
8814238
25.

Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.

Anaya JM, McGuff HS, Banks PM, Talal N.

Semin Arthritis Rheum. 1996 Apr;25(5):337-46. Review.

PMID:
8778989
26.

SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice.

Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, Talal N.

J Immunol. 1995 Sep 15;155(6):3205-12.

PMID:
7673733
27.

Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome).

Ogawa N, Dang H, Lazaridis K, McGuff HS, Aufdemorte TB, Talal N.

J Interferon Cytokine Res. 1995 Sep;15(9):759-67.

PMID:
8536103
28.

Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren's syndrome.

Chandrasekar B, McGuff HS, Aufdermorte TB, Troyer DA, Talal N, Fernandes G.

Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 1):291-6.

PMID:
7554451
29.

Primary Sjögren's syndrome in men.

Anaya JM, Liu GT, D'Souza E, Ogawa N, Luan X, Talal N.

Ann Rheum Dis. 1995 Sep;54(9):748-51.

30.

Sjögren's syndrome in childhood.

Anaya JM, Ogawa N, Talal N.

J Rheumatol. 1995 Jun;22(6):1152-8. Review.

PMID:
7674246
31.

Apoptosis and autoimmunity.

Ogawa N, Dang H, Talal N.

J Autoimmun. 1995 Feb;8(1):1-19. Review. No abstract available.

PMID:
7734031
32.

Induction of transcription factors in human T lymphocytes by aspirin-like drugs.

Flescher E, Ledbetter JA, Ogawa N, Vela-Roch N, Fossum D, Dang H, Talal N.

Cell Immunol. 1995 Feb;160(2):232-9.

PMID:
7720085
33.

Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction.

Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, Ogawa N, Talal N.

J Immunol. 1994 Dec 1;153(11):4880-9.

PMID:
7963551
34.

Historical overview of Sjögren's syndrome.

Talal N.

Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S3-4. No abstract available.

PMID:
7768047
35.

Oncogenes, autogenes, and rheumatic diseases.

Talal N.

Arthritis Rheum. 1994 Oct;37(10):1421-2. No abstract available.

PMID:
7945465
36.

Concluding remarks: autogenes and oncogenes.

Talal N.

Clin Immunol Immunopathol. 1994 Aug;72(2):208-9. Review. No abstract available.

PMID:
8050195
37.

Connective tissue diseases: one disease or many?

Moutsopoulos HM, Talal N.

Lupus. 1994 Feb;3(1):5-10. Review. No abstract available.

PMID:
8025587
38.

Sjögren's syndrome--close to cause and cure?

Talal N.

Adv Exp Med Biol. 1994;350:679-82. No abstract available.

PMID:
8030555
39.
40.

Retroviruses, apoptosis and autogenes.

Mountz JD, Talal N.

Immunol Today. 1993 Nov;14(11):532-6. Review.

PMID:
8274195
41.

Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome?

Moutsopoulos HM, Sarmas JH, Talal N.

Rheum Dis Clin North Am. 1993 Nov;19(4):909-12. Review.

PMID:
8265828
42.

Characterization of a cross-reactive idiotype on two human autoantibodies associated with systemic autoimmune disease.

DeKeyser F, Takei M, Dang H, DeKeyser H, Isenberg DA, Talal N.

Clin Immunol Immunopathol. 1993 Nov;69(2):155-60.

PMID:
7691456
43.

Lessons from autoimmunity.

Talal N.

Ann N Y Acad Sci. 1993 Aug 12;690:19-23. Review.

PMID:
8368737
44.

Lymphoproliferation in primary Sjögren's syndrome. Evidence of selective expansion of a B cell subset characterized by the expression of cross-reactive idiotypes.

Shokri F, Mageed RA, Maziak BR, Talal N, Amos N, Williams BD, Jefferis R.

Arthritis Rheum. 1993 Aug;36(8):1128-36.

PMID:
8343188
45.

Human kappa chain expression in a lambda phage vector: methods of isolating amplified cDNA affects cloning efficiency.

Lazaridis K, Dang H, Talal N.

Hum Antibodies Hybridomas. 1993 Jul;4(3):104-6.

PMID:
8357956
46.

Cloning of a human IgM autoantibody bearing a cross-reactive idiotype in a lambda expression vector: a new approach to studying autoantibodies.

Dang H, Lazaridis K, Talal N, Fischbach M, Sanz I.

Clin Immunol Immunopathol. 1993 Jun;67(3 Pt 1):249-56.

PMID:
8500272
47.

Interview with Norman Talal. What is going to happen tomorrow as far as Sjögren's syndrome is concerned?

Talal N.

Ann Med Interne (Paris). 1993;144(1):21-2. No abstract available.

PMID:
8503601
48.

Delayed type hypersensitivity in patients with rheumatoid arthritis.

Pope RM, Kniker WT, Talal N, Dauphinee M.

J Rheumatol. 1993 Jan;20(1):17-20.

PMID:
8441153
49.

Sjögren's syndrome and retroviral protein reactivity: reply.

Dang H, Talal N.

Arthritis Rheum. 1992 Nov;35(11):1405-6. No abstract available.

PMID:
1445468
50.

Systemic lupus erythematosus and Sjögren's syndrome.

Talal N.

Curr Opin Rheumatol. 1992 Oct;4(5):609-11. No abstract available.

PMID:
1419494

Supplemental Content

Support Center